EAM
CRL icon

EverPoint Asset Management’s Charles River Laboratories CRL Stock Holding History

EverPoint Asset Management’s Portfolio CRL Stock Details CRL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		$5.77M Buy
+75,700
New +$5.75M 0.14% 224
2016
Q2 		– Sell
-220,000
Closed -$16.7M – 410
2016
Q1 		$16.7M Sell
220,000
-25,000
-10% -$1.85M 0.47% 75
2015
Q4 		$19.7M Buy
+245,000
New +$17.7M 0.48% 64
2015
Q1 		– Sell
-250,000
Closed -$15.9M – 517
2014
Q4 		$15.9M Hold
250,000
– – 0.39% 94
2014
Q3 		$14.9M Buy
+250,000
New +$14.3M 0.4% 81

Other funds holding CRL

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
AI
Ariel Investments Chicago, Illinois $8.93B AUM 29.58% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Millennium Management
Millennium Management New York $134B AUM 35.51% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return